The LIT – Leibniz Institute for Immunotherapy (Foundation under Civil Law) researches and develops new immunotherapies for the treatment of tumors, autoimmune diseases, and transplant rejections.
The LIT - Leibniz Institute for Immunotherapy is seeking to support the working group
"Nucleid Acid Technologies" (led by Professor Katharina Höfer) with a
– starting immediately for approximately 34 hours per month, limited to 7 months.
Main tasks:
Requirements:
We offer:
The LIT is particularly committed to the compatibility of family and work.
Severely disabled applicants (m/f/d) will be given preference if their qualifications are essentially equal. Please indicate any existing severe disability in your application.
Please note that we cannot cover any costs that may arise from a potential interview.
For inquiries, please contact Prof. Dr. Katharina Höfer (Email: hoeferk@uni-marburg.de).
We look forward to receiving your detailed application.
Please apply via our Online - Application Portal the reference KH-2026-1.

Application deadline is August 30th, 2026.